Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33246418)

  • 1. An aggressive systemic mastocytosis preceded by ovarian dysgerminoma.
    Tsutsumi M; Miura H; Inagaki H; Shinkai Y; Kato A; Kato T; Hamada-Tsutsumi S; Tanaka M; Kudo K; Yoshikawa T; Kurahashi H
    BMC Cancer; 2020 Nov; 20(1):1162. PubMed ID: 33246418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A variant c-KIT mutation, D816H, fundamental to the sequential development of an ovarian mixed germ cell tumor and systemic mastocytosis with chronic myelomonocytic leukemia.
    Mitchell SG; Bunting ST; Saxe D; Olson T; Keller FG
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27781377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian germ cell tumor/mastocytosis with KIT mutation: A unique clinicopathological entity.
    Xiao P; Chen P; Lang X; An Q; Yang C; Chen S; Wang K; Chen N; Hao Y; Ding J; Li Z; Hu S; Xiao S
    Genes Chromosomes Cancer; 2022 Jan; 61(1):50-54. PubMed ID: 34553465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive systemic mastocytosis after germ cell tumor of the ovary: C-KIT mutation documentation in both disease states.
    Lee JW; Yang WS; Chung SY; Kang JH; Cho B; Kim HK; Kim KM; Jeong DC
    J Pediatr Hematol Oncol; 2007 Jun; 29(6):412-5. PubMed ID: 17551405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
    Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH
    PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trisomy 21 associated with ovarian dysgerminoma.
    Smucker JD; Roth LM; Sutton GP; Hurteau JA
    Gynecol Oncol; 1999 Sep; 74(3):512-4. PubMed ID: 10479522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ cell tumors of the ovary: the role of pathology in diagnosis and management.
    Jimerson GK
    Clin Obstet Gynecol; 1974 Mar; 17(1):229-39. PubMed ID: 4363500
    [No Abstract]   [Full Text] [Related]  

  • 9. Paraneoplastic Cholestasis Associated With Ovarian Dysgerminoma.
    Yeh KE; Marcus PS; Fong TL
    Obstet Gynecol; 2015 Aug; 126(2):431-434. PubMed ID: 25923022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropathy in association with an ovarian dysgerminoma.
    Ivanaj A; Pautier P; Rixe O; Duvillard P; Dubard T
    Gynecol Oncol; 2003 Apr; 89(1):168-70. PubMed ID: 12694672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotoxicosis induced by choriocarcinoma a report of two cases.
    O'Reilly S; Lyons DJ; Harrison M; Gaffney E; Cullen M; Clancy L
    Ir Med J; 1993; 86(4):124, 127. PubMed ID: 8395487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed ovarian germ cell tumor in a BRCA2 mutation carrier.
    Hamel N; Wong N; Alpert L; Galvez M; Foulkes WD
    Int J Gynecol Pathol; 2007 Apr; 26(2):160-4. PubMed ID: 17413983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and diagnostic significance of OCT4, CD117 and CD30 in germ cell tumors].
    Teng LH; Lu DH; Xu QZ; Fu YJ; Yang H; He ZL
    Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):711-5. PubMed ID: 16536313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anatamo-pathological aspects of malignant ovarian tumors in children. Apropos of 16 cases].
    Makni MK; Mzabi-Regaya S; Kattech A; Chadli A
    Arch Inst Pasteur Tunis; 1988; 65(1-2):87-98. PubMed ID: 2845875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant ovarian germ cell tumors. Current status of diagnosis and treatment].
    Torres-Lobatón A
    Ginecol Obstet Mex; 2014 Mar; 82(3):177-87. PubMed ID: 24779273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysgerminoma of the ovary in a patient with triple-X syndrome.
    Kemp B; Hauptmann S; Schröder W; Amo-Takyi B; Leeners B; Rath W
    Int J Gynaecol Obstet; 1995 Jul; 50(1):51-3. PubMed ID: 7556861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late relapse of ovarian dysgerminoma: case report and literature review.
    Bekaii-Saab T; Einhorn LH; Williams SD
    Gynecol Oncol; 1999 Jan; 72(1):111-2. PubMed ID: 9889041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
    Jawhar M; Schwaab J; Horny HP; Sotlar K; Naumann N; Fabarius A; Valent P; Cross NC; Hofmann WK; Metzgeroth G; Reiter A
    Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncommon Metastasis of Ovarian Dysgerminoma: A Case Report and Review of the Literature.
    Tîrnovanu MC; Florea ID; Tănase A; Toma BF; Cojocaru E; Ungureanu C; Lozneanu L
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34071828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germ Cell Tumors of the Female Genital Tract.
    Euscher ED
    Surg Pathol Clin; 2019 Jun; 12(2):621-649. PubMed ID: 31097117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.